How has recent evidence and the ESC 2023 guidelines changed management of heart failure?
Featuring
Professor Christiane Angermann | Germany
Professor Ricardo Carvalho | Portugal
Related content
Document ID: PC-MY-103753
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
Clinical relationship between the heart and the kidneys
Christiane Angermann (Germany) | Ricardo Carvalho (Portugal)
Why is empagliflozin now a preferred heart failure treatment, coming from a history of diabetes?
Theresa McDonagh (United Kingdom)
What's new for the treatment of chronic heart failure from the ESC 2023 guidelines?
Heart Failure 360: Early protection for every heart failure patient
02:13:04